MSB 1.56% 97.5¢ mesoblast limited

Growing doubt on COVID-19 Application, page-3747

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    Well, you should invest if you think something will get approved that will make money for the company.

    The trouble is, this company never quite delivers. It’s always just around the corner. Has been for 10 years. Always exciting times just over the horizon. Big things. Huge things. But they never land.

    There’s always, but always suspect trial results. Missed end points. “Fantastic” data that has been sliced and diced … not accepted by the FDA or partners who walk away.

    The product is expensive and difficult to manufacture. The quality control problems are devilishly hard to get right (still haven’t fixed the problems).

    Really, no one trusts the company. But the biggest thing is that after all this time and money msb has burnt through over nearly 2 decades they still haven’t produced an approved treatment. I mean, if it was such a miracle cure, the trial data would be conclusive and someone would have partnered, bought it out, or it would have been approved by now.

    That’s why it’s not trusted. The ones who really know don’t want to touch it. It’s the punters who get sucked in.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.